Product Program year 2024 Source: CMS Open Payments

Arthrex

Device Knee & Hip - Implants - Suspensory Fixation - Quad Tendon ACL TRI

PDI 00888867344761

Open in the dashboard

General payments

$669,407

10 payments

Research payments

$0

0 payments

Through program year 2024, $669,407 in general payments and $0 in research payments were reported against Arthrex (Suspensory Fixation - Quad Tendon ACL TRI).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2024 General $534,184 7
2023 General $135,224 3

Breakdown

Who paid General payments · program years 2023–2024
  1. Arthrex, Inc. $669,407 10 payments
Top recipients General payments · program year 2024
  1. Walter Lowe Sports Medicine · Houston, TX $221,786 42% · 4 payments
  2. James Guerra Orthopaedic Surgery · Naples, FL $106,533 20% · 1 payment
  3. Thomas Deberardino Sports Medicine · San Antonio, TX $105,389 20% · 1 payment
  4. Jeffrey Jackson Orthopaedic Surgery · Salt Lake City, UT $100,476 19% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Sports Medicine Orthopaedic Surgery $327,175 61% · 2 practitioners
  2. Orthopaedic Surgery $207,008 39% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Texas $327,175 61% · 2 recipients
  2. Florida $106,533 20% · 1 recipient
  3. Utah $100,476 19% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

10 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record